Andreea Gratiana Boiangiu

Dr. Andreea Gratiana Boiangiu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
SPSimona Daniela Popescu
Simona Daniela Popescu
ABAndreea Gratiana Boiangiu
Andreea Gratiana Boiangiu
SRSima Romina-Marina
Sima Romina-Marina
LBLiviu Bilteanu
Liviu Bilteanu
SVSimona Vladareanu
Simona Vladareanu
RVRadu Vladareanu
Radu Vladareanu
Background: Human Papilloma Virus (HPV) represents the most prevalent genital infection in young women of reproductive age. Objective: This systematic review aims to estimate the effect of HPV infection during pregnancy and assess the correlation between HPV and adverse pregnancy outcomes. Materials and methods: The search strategy has been developed based on the PICOS framework: Population (pregnant women infected with HPV), Intervention (HPV infection confirmed by molecular tests), Comparator (pregnant women without HPV infection), Outcomes (adverse pregnancy outcomes) and Study design (observational studies). We searched PubMed, Web of Science, and Scopus databases on 8 January 2022 by using the following keywords: “HPV”, “prematurity”, “preterm birth”, “miscarriage”, “premature rupture of membranes”, “adverse pregnancy outcome”, “low birth weight”, “fetal growth restriction”, “pregnancy-induced hypertensive disorders”, “preeclampsia”. Selection criteria were HPV infection confirmed within maximum 2 years before pregnancy with a molecular test and adverse pregnancy outcomes. (Results: Although numerous studies are conducted on this topic, data are still controversial regarding identifying maternal HPV infection as a risk factor for adverse pregnancy outcomes. More prospective large cohort studies are needed to prove a causative relationship.

13 May 2026 in Life
Verified
Journal Article
Open access
PDF file
Delia Maria BogheanuDelia Maria Bogheanu
Delia Maria Bogheanu
ABAwatif Jaafar Sadeq Bayati
Awatif Jaafar Sadeq Bayati
MPMircea-Octavian Poenaru
Mircea-Octavian Poenaru
OOOctavian Gabriel Olaru
Octavian Gabriel Olaru
GGGabriel Petre Gorecki
Gabriel Petre Gorecki
Liana PlesLiana Ples
Liana Ples
This narrative review examines current evidence on the management of cervical intraepithelial neoplasia (CIN) during pregnancy, a clinical scenario requiring a balance between maternal oncologic safety and fetal well-being. A qualitative synthesis was conducted using major databases (PubMed, Google Scholar, Cochrane Library, and ScienceDirect), focusing on studies published between 2019 and 2025, supplemented by key earlier publications. A total of 37 studies and international guidelines were included. Available evidence suggests that pregnancy does not substantially alter the natural history of human papillomavirus infection. Although CIN is generally associated with low progression rates and notable postpartum regression, findings remain heterogeneous and largely based on retrospective data. Colposcopy is essential for excluding invasive disease, while invasive procedures are reserved for suspected malignancy. Most guidelines support conservative management with surveillance during pregnancy and postpartum reassessment. HPV testing offers higher sensitivity, whereas cytology remains widely used due to its specificity. The impact of delivery mode remains inconclusive. Overall, current recommendations rely on limited evidence and should be interpreted with caution. Further prospective studies are needed to refine pregnancy-specific management strategies.